GETI-B:STO
Getinge publ AB
249,60 SEK
arrow_downward
-0,16%(-0,40) 1D
8-окт., 17:29:48 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
248,90 SEK
High
251,20 SEK
Low
247,60 SEK
Mkt. cap
62,89 млд
Avg. vol.
588,10 миң
Volume
635,54 миң
Dividend
1,90%
Quarterly dividend
1,19 SEK
Ex-dividend date
2026-ж., 22-апр.
P/E ratio
25,42
52-wk high
254,10 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 млн
No. of employees
12 миң
Open
248,90 SEK
High
251,20 SEK
Low
247,60 SEK
Mkt. cap
62,89 млд
Avg. vol.
588,10 миң
Volume
635,54 миң
Dividend
1,90%
Quarterly dividend
1,19 SEK
Ex-dividend date
2026-ж., 22-апр.
P/E ratio
25,42
52-wk high
254,10 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 млн
No. of employees
12 миң
News stories
From web sources and news partners
AD HOC NEWS
·
55 мүнөт мурун
Getinge announces Eric Honroth departure as Getinge stock costs EUR 22.32
TipRanks
·
1 күн мурун
Getinge’s Life Science President Eric Honroth to Step Down
www.marketscreener.com
·
1 күн мурун
Getinge's Business Area Head Eric Honroth Leaves the Company
TipRanks
·
1 күн мурун
Getinge Schedules Q3 2026 Report Release and Investor Call
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB